Damona Pharmaceuticals
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
250 College St Rm 134, Toronto, Ontario,...Website
www.damonapharma.comRevenue
$6.7 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Damona Pharmaceuticals
Damona Pharmaceuticals is focused on developing precision neuromedicines aimed at reversing cognitive deficits associated with brain disorders. Their lead program is a positive allosteric modulator targeting the α5-GABA-A receptor, with potential applications in treating cognitive deficits across various brain disorders. The company aims to restore connections between brain cells and improve the quality of life for patients suffering from cognitive impairments. Damona's vision is to facilitate healthy cognitive processes in individuals affected by neurological and psychiatric diseases.Explore more
Damona Pharmaceuticals Org Chart
RR
Chief Medical Officer, Consulting
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Damona Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Damona Pharmaceuticals has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Damona Pharmaceuticals launches new products
Check out if Damona Pharmaceuticals is spiking on competitors!
Check if Damona Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Damona Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Damona Pharmaceuticals
Click to see if Damona Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Damona Pharmaceuticals recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Damona Pharmaceuticals as Masked Content
Find more new buyers
Compare Similar Companies to Damona Pharmaceuticals
Compare insights from companies similar to Damona Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Damona Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Damona Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Damona Pharmaceuticals.
Damona Pharmaceuticals Tech Stack
A closer look at the technologies used by Damona Pharmaceuticals
Damona Pharmaceuticals News & Media
Damona Pharmaceuticals Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of DPX-101, a Positive Allosteric Modulator Targeting the α5-GABA-A Receptor Subtype Selectively, with Broad Therapeutic Potential to Treat Cognitive Deficits Across Brain Disorders
— In preclinical models, small molecule DPX-101 demonstrated highly selective target activation and expected electrophysiological effects as well as improved cognitive performance in behavioral tests of frontal cortex and hippocampal functions — TORONTO, Nov. 4, 2024 /PRNewswire/ --...DAMONA Pharmaceuticals Raises US$5.5 Million Seed Stage Financing to Advance Lead ...
TORONTO, ON / ACCESSWIRE / September 26, 2022 / DAMONA Pharmaceuticals today announced the closing of a seed stage financing round to support the development of its lead therapeutic for the treatment of cognitive symptoms associated with depression and diseases of aging. The syndicated investment was co-led by the Angelini Lumira Biosciences Fund and Noetic Fund and included participation from Toronto Innovation Acceleration Partners (TIAP), and
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Damona Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Damona Pharmaceuticals is focused on developing precision neuromedicines aimed at reversing cognitive deficits associated with brain disorders. Their lead program is a positive allosteric modulator targeting the α5-GABA-A receptor, with potential applications in treating cognitive deficits across various brain disorders. The company aims to restore... Read More
